Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Gramicidin
2. Gramicidin A
3. Gramicidin A(1)
4. Gramicidin B
5. Gramicidin C
6. Gramicidin D
7. Gramicidin Dubos
8. Gramicidin J
9. Gramicidin K
10. Gramicidin Nf
11. Gramicidin P
12. Gramicidin S
13. Gramicidin, Linear
14. Gramicidins
15. Gramoderm
16. Linear Gramicidin
1. Gramicidin
2. 1405-97-6
3. Gramicidinum
4. Gramicidine
5. Gramoderm
6. 9,27-bis(3-aminopropyl)-3,21-dibenzyl-6,24-bis(2-methylpropyl)-12,30-di(propan-2-yl)-1,4,7,10,13,19,22,25,28,31-decazatricyclo[31.3.0.015,19]hexatriacontane-2,5,8,11,14,20,23,26,29,32-decone
7. Gramicidine [inn-french]
8. Gramicidinum [inn-latin]
9. Gramicidina [inn-spanish]
10. Gramicidin [usp:inn:ban]
11. Unii-5ie62321p4
12. Einecs 215-790-4
13. Neosporin Ophthalmic Solution
14. Schembl163104
15. Nsc183503
16. Akos026750031
17. 5ie62321p4
18. Nsc 757043
19. Gramicidin From Bacillus Aneurinolyticus (bacillus Brevis)
20. Hco-val-gly-d-leu-ala-d-val-val-d-val-[trp-d-leu]3-trp-nh2-ch2ch2oh
Molecular Weight | 1882.3 g/mol |
---|---|
Molecular Formula | C99H140N20O17 |
XLogP3 | 10.7 |
Hydrogen Bond Donor Count | 21 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 52 |
Exact Mass | 1882.07388791 g/mol |
Monoisotopic Mass | 1881.07053308 g/mol |
Topological Polar Surface Area | 549 Ų |
Heavy Atom Count | 136 |
Formal Charge | 0 |
Complexity | 3980 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 14 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
R - Respiratory system
R02 - Throat preparations
R02A - Throat preparations
R02AB - Antibiotics
R02AB30 - Gramicidin
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
49
PharmaCompass offers a list of Gramicidin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gramicidin manufacturer or Gramicidin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gramicidin manufacturer or Gramicidin supplier.
PharmaCompass also assists you with knowing the Gramicidin API Price utilized in the formulation of products. Gramicidin API Price is not always fixed or binding as the Gramicidin Price is obtained through a variety of data sources. The Gramicidin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gramicidina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gramicidina, including repackagers and relabelers. The FDA regulates Gramicidina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gramicidina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gramicidina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gramicidina supplier is an individual or a company that provides Gramicidina active pharmaceutical ingredient (API) or Gramicidina finished formulations upon request. The Gramicidina suppliers may include Gramicidina API manufacturers, exporters, distributors and traders.
click here to find a list of Gramicidina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gramicidina DMF (Drug Master File) is a document detailing the whole manufacturing process of Gramicidina active pharmaceutical ingredient (API) in detail. Different forms of Gramicidina DMFs exist exist since differing nations have different regulations, such as Gramicidina USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gramicidina DMF submitted to regulatory agencies in the US is known as a USDMF. Gramicidina USDMF includes data on Gramicidina's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gramicidina USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gramicidina suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gramicidina Drug Master File in Japan (Gramicidina JDMF) empowers Gramicidina API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gramicidina JDMF during the approval evaluation for pharmaceutical products. At the time of Gramicidina JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gramicidina suppliers with JDMF on PharmaCompass.
A Gramicidina CEP of the European Pharmacopoeia monograph is often referred to as a Gramicidina Certificate of Suitability (COS). The purpose of a Gramicidina CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gramicidina EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gramicidina to their clients by showing that a Gramicidina CEP has been issued for it. The manufacturer submits a Gramicidina CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gramicidina CEP holder for the record. Additionally, the data presented in the Gramicidina CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gramicidina DMF.
A Gramicidina CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gramicidina CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gramicidina suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gramicidina as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gramicidina API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gramicidina as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gramicidina and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gramicidina NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gramicidina suppliers with NDC on PharmaCompass.
Gramicidina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gramicidina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gramicidina GMP manufacturer or Gramicidina GMP API supplier for your needs.
A Gramicidina CoA (Certificate of Analysis) is a formal document that attests to Gramicidina's compliance with Gramicidina specifications and serves as a tool for batch-level quality control.
Gramicidina CoA mostly includes findings from lab analyses of a specific batch. For each Gramicidina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gramicidina may be tested according to a variety of international standards, such as European Pharmacopoeia (Gramicidina EP), Gramicidina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gramicidina USP).